PROCESSO PER LA PURIFICAZIONE DEL LATANOPROST, ANALOGO SINTETICO DELLA PROSTAGLANDINA PGF2ALFA

The present invention refers to a process for the purification of Latanoprost (13,14-dihydro-17-phenyl-18,19,20-trinor-PGF 2± -isopropyl ester), a synthetic analogue of the natural prostaglandin PGF 2± used for the treatment of eye pressure pathologies.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DI BRISCO ROBERTO, COSTANTINO FRANCESCA
Format:	Patent
Sprache:	ita
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	DI BRISCO ROBERTO COSTANTINO FRANCESCA
description	The present invention refers to a process for the purification of Latanoprost (13,14-dihydro-17-phenyl-18,19,20-trinor-PGF 2± -isopropyl ester), a synthetic analogue of the natural prostaglandin PGF 2± used for the treatment of eye pressure pathologies.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ITMI20082330A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ITMI20082330A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ITMI20082330A13</originalsourceid><addsrcrecordid>eNqNi8EKAiEURWfTIqp_ENoWmG7aPhy1B-YTtU2LhiFsFTUw_T8p9AGtLveec5fdLURSOiViQUfmgIVLRIMKrkhes167OmbwVL2Udww8OLLEEvqsMypqSrs1DNaB79HXao0AZ2DdLR7jcy6bX666rdFZnfZleg9lnsZ7eZXPgPmMgvOjkJLDQf5nfQH6lzQU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESSO PER LA PURIFICAZIONE DEL LATANOPROST, ANALOGO SINTETICO DELLA PROSTAGLANDINA PGF2ALFA</title><source>esp@cenet</source><creator>DI BRISCO ROBERTO ; COSTANTINO FRANCESCA</creator><creatorcontrib>DI BRISCO ROBERTO ; COSTANTINO FRANCESCA</creatorcontrib><description>The present invention refers to a process for the purification of Latanoprost (13,14-dihydro-17-phenyl-18,19,20-trinor-PGF 2± -isopropyl ester), a synthetic analogue of the natural prostaglandin PGF 2± used for the treatment of eye pressure pathologies.</description><language>ita</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100625&DB=EPODOC&CC=IT&NR=MI20082330A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100625&DB=EPODOC&CC=IT&NR=MI20082330A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DI BRISCO ROBERTO</creatorcontrib><creatorcontrib>COSTANTINO FRANCESCA</creatorcontrib><title>PROCESSO PER LA PURIFICAZIONE DEL LATANOPROST, ANALOGO SINTETICO DELLA PROSTAGLANDINA PGF2ALFA</title><description>The present invention refers to a process for the purification of Latanoprost (13,14-dihydro-17-phenyl-18,19,20-trinor-PGF 2± -isopropyl ester), a synthetic analogue of the natural prostaglandin PGF 2± used for the treatment of eye pressure pathologies.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi8EKAiEURWfTIqp_ENoWmG7aPhy1B-YTtU2LhiFsFTUw_T8p9AGtLveec5fdLURSOiViQUfmgIVLRIMKrkhes167OmbwVL2Udww8OLLEEvqsMypqSrs1DNaB79HXao0AZ2DdLR7jcy6bX666rdFZnfZleg9lnsZ7eZXPgPmMgvOjkJLDQf5nfQH6lzQU</recordid><startdate>20100625</startdate><enddate>20100625</enddate><creator>DI BRISCO ROBERTO</creator><creator>COSTANTINO FRANCESCA</creator><scope>EVB</scope></search><sort><creationdate>20100625</creationdate><title>PROCESSO PER LA PURIFICAZIONE DEL LATANOPROST, ANALOGO SINTETICO DELLA PROSTAGLANDINA PGF2ALFA</title><author>DI BRISCO ROBERTO ; COSTANTINO FRANCESCA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ITMI20082330A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ita</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>DI BRISCO ROBERTO</creatorcontrib><creatorcontrib>COSTANTINO FRANCESCA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DI BRISCO ROBERTO</au><au>COSTANTINO FRANCESCA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESSO PER LA PURIFICAZIONE DEL LATANOPROST, ANALOGO SINTETICO DELLA PROSTAGLANDINA PGF2ALFA</title><date>2010-06-25</date><risdate>2010</risdate><abstract>The present invention refers to a process for the purification of Latanoprost (13,14-dihydro-17-phenyl-18,19,20-trinor-PGF 2± -isopropyl ester), a synthetic analogue of the natural prostaglandin PGF 2± used for the treatment of eye pressure pathologies.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	ita
recordid	cdi_epo_espacenet_ITMI20082330A1
source	esp@cenet
title	PROCESSO PER LA PURIFICAZIONE DEL LATANOPROST, ANALOGO SINTETICO DELLA PROSTAGLANDINA PGF2ALFA
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A15%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DI%20BRISCO%20ROBERTO&rft.date=2010-06-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EITMI20082330A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true